510(k) Report

510(k) · Cleared

Cleared

Fleboset Multiple

K040456510(k) TraditionalCleared Mar 9, 200415-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Laboratorios Grifols, S.A. · LHI Set, I.V. Fluid Transfer

Cleared on Mar 9, 2004 as substantially equivalent to K894827 (Baxter Healthcare Corp, 1989) and 2 other predicates after a 15-day review. Its family tree reaches back 3 generations to 1991. 11 later devices descend from it.

Decided
Mar 9, 2004
Review
15 days
Class
Class II
Product code
LHI
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K903493 (1991). 4 ancestors in all, the oldest K894827 (1989). 11 later devices descend from it, 5 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1989: 1 other ancestor2008: 1 descendant cleared2025: 1 descendant cleared2011: 1 descendant cleared2010: 1 descendant cleared2005: 1 descendant cleared2018: 1 descendant cleared2015: 1 descendant cleared2017: 1 descendant cleared2022: 1 descendant cleared2021: 1 descendant cleared2019: 1 descendant clearedK903493 · Namic Contrast Savings Delivery System · North American Instrument Corp. · 1991K961794 · Fluid Administration Set - Contrast Manager · Merit Medical Systems, Inc. · 1996K022431 · Medrad Transfer Set · Medrad, Inc. · 20021990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 5 descendants2 generations forward: 2 descendants3 generations forward: 4 descendants K022431 · Medrad Transfer Set · Medrad, Inc. · 2002K961794 · Fluid Administration Set - Contrast Manager · Merit Medical Systems, Inc. · 1996K903493 · Namic Contrast Savings Delivery System · North American Instrument Corp. · 19910
  1. Root · 3 generations backK903493 Namic Contrast Savings Delivery SystemNorth American Instrument Corp. · 1991
  2. 2 generations backK961794 Fluid Administration Set - Contrast ManagerMerit Medical Systems, Inc. · 1996
  3. 1 generation backK022431 Medrad Transfer SetMedrad, Inc. · 2002
  4. This deviceK040456 Fleboset MultipleLaboratorios Grifols, S.A. · 2004
  5. Descendant · cites it directly · 6 of its ownK050339 Set Gri-Fill 3.0-1 Way, 2 Ways, MultipleLaboratorios Grifols, S.A. · 2005
  6. Descendant · 2 generations on · 3 of its ownK152441 KIRO SetKiro Robotics S.L. · 2015
  7. Descendant · cites it directly · 2 of its ownK082752 QuickpinLaboratorios Grifols, S.A. · 2008
  8. Descendant · 2 generations on · 1 of its ownK170110 Diana Medication Transfer SetIcu Medical, Inc. · 2018 · Recalled
  9. Descendant · cites it directly · 1 of its ownK093182 Set Gri-Fill 3.0Laboratorios Grifols, S.A. · 2010

Showing 5 of 11 descendants. See all descendants

Descendants cleared per year

2005: 12008: 12010: 12011: 12015: 12017: 12018: 12019: 12021: 12022: 12025: 1
2005high 1 (2005) · low 0 (2006)2026

Most influential descendants

Showing 5 of 11 · See all
  • K050339Set Gri-Fill 3.0-1 Way, 2 Ways, MultipleLaboratorios Grifols, S.A. · 2005 · cites it directly6descendants
  • K152441KIRO SetKiro Robotics S.L. · 2015 · 2 generations on3descendants
  • K082752QuickpinLaboratorios Grifols, S.A. · 2008 · cites it directly2descendants
  • K170110Diana Medication Transfer SetIcu Medical, Inc. · 2018 · 2 generations on1descendant
  • K093182Set Gri-Fill 3.0Laboratorios Grifols, S.A. · 2010 · cites it directly1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K903493Namic Contrast Savings Delivery SystemNorth American Instrument Corp.1991—
−2K961794Fluid Administration Set - Contrast ManagerMerit Medical Systems, Inc.1996—
−1K022431Medrad Transfer SetMedrad, Inc.2002—
0 (this device)K040456Fleboset MultipleLaboratorios Grifols, S.A.2004—
+1K050339Set Gri-Fill 3.0-1 Way, 2 Ways, MultipleLaboratorios Grifols, S.A.2005—
+2K152441KIRO SetKiro Robotics S.L.2015—
+1K082752QuickpinLaboratorios Grifols, S.A.2008—
+2K170110Diana Medication Transfer SetIcu Medical, Inc.20181
+1K093182Set Gri-Fill 3.0Laboratorios Grifols, S.A.2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200510
200810
201010
201110
201510
201710
201810
201910
202110
202210
202510
FIG. 1 — Lineage of K040456, 1991–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LHI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LHI device

  1. #1 K252987 ADRx™ Admixture Devicescore 12.4 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K894827Automix 3+3 Compounder
Summary page 2
…ures of both predicate and new devices. Feature Characteristic / FLEBOSET MULTIPLE PREDICATES BAXTER Automix 3+3 (transfer set presented together with compounder) K894827 MEDRAD Transfer Set K022431 MERIT MEDICAL Transfer Sets K961794 1. |intended use/ Cleims FLEBOSET MULTIPLE is an ancillary de…
Baxter Healthcare Corp19891
*K022431Medrad Transfer Set
Summary page 2
…w devices. Feature Characteristic / FLEBOSET MULTIPLE PREDICATES BAXTER Automix 3+3 (transfer set presented together with compounder) K894827 MEDRAD Transfer Set K022431 MERIT MEDICAL Transfer Sets K961794 1. |intended use/ Cleims FLEBOSET MULTIPLE is an ancillary device used as fluid pathway th…
Medrad, Inc.2002—
*K961794Fluid Administration Set - Contrast Manager
Summary page 2
…FLEBOSET MULTIPLE PREDICATES BAXTER Automix 3+3 (transfer set presented together with compounder) K894827 MEDRAD Transfer Set K022431 MERIT MEDICAL Transfer Sets K961794 1. |intended use/ Cleims FLEBOSET MULTIPLE is an ancillary device used as fluid pathway through which substances from 6 glass s…
Merit Medical Systems, Inc.1996—

Also cleared against K894827: 1 other device →

What descends from it? (11)

See all 11

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K050339Set Gri-Fill 3.0-1 Way, 2 Ways, MultipleLaboratorios Grifols, S.A.20056
K082752QuickpinLaboratorios Grifols, S.A.20082
K093182Set Gri-Fill 3.0Laboratorios Grifols, S.A.20101
K243404HyHub™ and HyHub™ Duo Vial Access DevicesTakeda Pharmaceuticals20250
K102590Fleboset DoubleLaboratorios Grifols, S.A.20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 4 companies; a new generation was cleared every 5.4 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • Of its descendants, K050339 (Laboratorios Grifols, S.A., 2005) has gone furthest, with 6 descendants of its own.
  • 1 other device also cites its predicate K894827.

How does its category compare?

All LHI devices

LHI Set, I.V. Fluid Transfer: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LHI

6in 2025

2007: 32008: 42009: 82010: 52011: 32012: 52013: 42014: 62015: 32016: 32017: 52018: 12019: 42020: 32021: 32022: 62023: 52024: 92025: 62026 (partial year): 2
2007high 9 (2024) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LHI

196in 2025

2007: 89 days median2008: 154 days median2009: 95 days median2010: 139 days median2011: 99 days median2012: 127 days median2013: 102 days median2014: 63 days median2015: 99 days median2016: 159 days median2017: 56 days median2019: 247 days median2020: 189 days median2021: 396 days median2022: 278 days median2023: 90 days median2024: 166 days median2025: 196 days median
2007high 396 (2021) · low 56 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LHI

1in 2024

2007: 12008: 32009: 12010: 32011: 122013: 32016: 1, 1 Class I2017: 12018: 3, 3 Class I2019: 12022: 22023: 2, 2 Class I2024: 12026 (partial year): 1
2007high 12 (2011) · low 0 (2012)2026

Class I (6 since 2007) Class II/III not classified

Adverse event reports per year · LHI

1,334in 2025

2007: 182008: 272009: 372010: 492011: 1552012: 5292013: 1542014: 1552015: 1282016: 2192017: 5362018: 1,4992019: 1,6342020: 1,1712021: 9332022: 1,8342023: 1,0472024: 1,2702025: 1,334
2007high 1,834 (2022) · low 18 (2007)2025

MAUDE reports naming product code LHI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007389118
20084154327
2009895137
20105139349
201139912155
201251270529
201341023154
20146630155
20153990128
201631591 (1)219
20175561536
20181—3 (3)1,499
2019424711,634
2020318901,171
202133960933
2022627821,834
20235902 (2)1,047
2024916611,270
2025619601,334
20262—1—

What is it indicated for?

FLEBOSET MULTIPLE is an ancillary device used as fluid pathway through which substances from 6 glass source flasks containing the same solution may be continuously delivered for:

(a) Pharmacy compounding, when used in conjunction with the GRI-FILL 2.0 pharmacy compounding device and associated transfer sets, and

(b) I.V. administration, when used in conjunction with a gravity or pump infusion set to channel the solution from the source containers to the infusion set.

The device should not be used with lipids.

This device is intended to be used by trained health-care personnel. It is restricted to sale by or on order of a physician.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K040456: Fleboset Multiple.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K040456

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026